Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAnxiety is not listed as a common side effect of tirzepatide in the UK prescribing information, and clinical trial data from the SURMOUNT programme did not identify it as a frequently reported problem. That said, some people starting treatment do notice changes in how they feel emotionally, and those experiences deserve a clear, honest explanation. Tirzepatide is a prescription-only medicine, and any concerns about mood or mental wellbeing while taking it should be discussed with your prescriber. This page draws on the published evidence and NHS guidance on tirzepatide to give you a grounded picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common thread in online conversations is the assumption that because tirzepatide affects appetite and gut hormones so powerfully, it must also be doing something equally dramatic to mood. The evidence does not support that framing. In the SURMOUNT-1 trial, which followed nearly 2,500 adults over 72 weeks, the side effects most commonly reported were nausea, diarrhoea, vomiting, constipation, and reduced appetite — not anxiety, low mood, or psychological disturbance. The NHS tirzepatide medicines page lists the recognised side effects in order of frequency, and anxiety does not feature among them.
That does not mean emotional discomfort is invented or irrelevant. What it means is that a reported feeling of anxiety during the early weeks of treatment is more likely to reflect the body adjusting to a significant physiological change than the medicine directly triggering anxiety as a pharmacological action. Nausea, fatigue, and eating far less than usual are all uncomfortable experiences, and discomfort can feel unsettling. Distinguishing between an indirect ripple effect and a direct drug action matters, because the appropriate response differs.
If you had pre-existing anxiety before starting tirzepatide, it is worth noting that the medicine has not been studied as a treatment for anxiety disorders, and if you are asking whether Mounjaro can cause anxiety or worsen an existing condition, its interaction with anxiety conditions is not well characterised in the literature. A conversation with your prescriber before starting, not after symptoms appear, is the more straightforward path.
Several indirect mechanisms can produce something that feels like anxiety without the medicine acting on mood receptors directly. Tirzepatide slows gastric emptying significantly, which changes the rhythm of how energy enters the bloodstream. For people who are sensitive to blood-sugar fluctuations, this can occasionally produce symptoms (shakiness, light-headedness, a sense of unease) that pattern-match to anxiety. This is particularly relevant if calorie intake drops sharply in the early weeks, which it often does as appetite falls.
Sleep can also shift during the early stages of treatment. Some people sleep differently when losing weight quickly, especially if they had sleep apnoea that begins to resolve. Disrupted sleep is one of the more reliable triggers of daytime anxiety, and it would be a mistake to attribute that anxiety to tirzepatide directly when the mechanism is several steps removed.
There is also a straightforward psychological dimension. Starting a new prescription medicine for weight management can bring its own emotional weight: hope, apprehension, worry about whether it will work, or concern about what happens if it does not. Our overview of Mounjaro side effects addresses the full emotional and physical range of early treatment experiences if you want a broader picture of what people commonly report.
The MHRA asks prescribers and patients to remain alert to mood changes on any medicine, and tirzepatide is no exception. If you notice anxiety that is new, worsening, persistent beyond the first few weeks, or accompanied by low mood, thoughts of self-harm, or significant behavioural changes, those symptoms warrant prompt contact with your prescriber or GP rather than waiting to see if they resolve.
You can also report any suspected side effect, including psychological ones, through the MHRA's Yellow Card scheme, this kind of reporting is genuinely useful and helps the regulator build a more complete post-market safety picture for newer medicines. Tirzepatide carries a Black Triangle (▼) status in the UK, meaning it is subject to additional monitoring precisely because it is relatively new; that does not mean it is unsafe, but it does mean patient reports carry weight.
For people already taking medicines for anxiety or depression, the relevant question is whether tirzepatide interacts with those medicines. Slowed gastric emptying can affect the rate at which some oral medicines are absorbed, so your prescriber needs a full medication history before approving treatment. Our dedicated page on whether tirzepatide can cause anxiety looks at this interaction question in more depth.
If the early weeks feel emotionally rocky, a few practical anchors are worth considering before concluding that tirzepatide is the cause. First, keep meals small and protein-rich even when appetite is low, an almost-empty stomach amplifies nausea and energy dips. Second, maintain a consistent routine around when you take your injection; many people find it helps to keep the pen in the fridge door so the weekly moment is predictable and unremarkable rather than something they have to think about. Predictability reduces low-level background stress.
Third, if appetite suppression is severe enough to interfere with daily functioning, that is clinical information your prescriber needs, dose titration exists for exactly this reason, and there is no obligation to push through an intolerable experience. The question of why Mounjaro produces these feelings in some people is explored in more detail if you want the physiological reasoning behind the adjustment period.
For anyone who wants a fuller picture of the relationship between Mounjaro and anxiety, including how mood, appetite suppression, and physiological adjustment interact across the treatment period, our dedicated resource brings that evidence together in one place. For anyone weighing up whether treatment is right for them in the first place, our prescribers at the consultation page carry out a full clinical review, including mental health history, before any prescription is issued. The cost context around private treatment, for anyone factoring that into their decision, is covered on our Mounjaro price comparison page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.